FCC Approves $3.54B Nexstar-Tegna Merger, Waiving Broadcast Ownership Cap 
Jay Bhattacharya to Continue Leading CDC as White House Searches for Permanent Director 
Trump White House Unveils National AI Policy Framework for Congress 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies 
Cuba Receives Humanitarian Aid Convoy Amid U.S. Sanctions 
Cyberattack on Stryker Triggers U.S. Government Warning Over Microsoft Intune Security 
Intermittent fasting doesn’t have an edge for weight loss, but might still work for some 
Air Canada Express Crash at LaGuardia: Controller Distracted by Prior Emergency 
FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide 
Iran-U.S. Negotiations: Tehran Reviews American Peace Proposal Amid Ongoing Gulf Conflict 
New Zealand Tightens Immigration Laws to Combat Crime and Asylum Abuse 
Democratic Attorneys General Sue Trump Administration Over CDC Childhood Vaccine Schedule Changes 
ICE Arrest of Guatemalan Woman at San Francisco Airport Sparks Outrage 
Pakistan's Diplomatic Rise: Mediating U.S.-Iran Peace Talks 
Trump Issues 48-Hour Ultimatum to Iran Over Strait of Hormuz, Threatens Power Grid Strikes 
FEMA Reinstates $1 Billion Disaster Prevention Grant Program After Court Order 
Trump Administration Opens Two New Investigations Into Harvard Over Discrimination and Antisemitism 
The United States is moving closer to naming a permanent leader for the Centers for Disease Control and Prevention, according to a top health official. Chris Klomp, chief counselor at the Department of Health and Human Services, expressed strong confidence following a series of interviews with potential candidates for the CDC director role.
"I'm very optimistic that we will select an excellent leader for that agency," Klomp stated during a Stat News health conference, signaling that the selection process is well underway.
The CDC has been operating under a succession of acting directors since former director Susan Monarez was dismissed last August after opposing vaccine policy changes proposed by Health Secretary Robert F. Kennedy Jr. Jim O'Neill briefly stepped in as acting director before being replaced by NIH Director Jay Bhattacharya following a leadership restructuring last month.
Kennedy's sweeping vaccine policy reforms have significantly disrupted the nation's public health infrastructure. A federal judge recently issued a temporary block on major components of those changes, including most of Kennedy's appointments to the CDC's vaccine advisory committee and proposed updates to childhood immunization recommendations. The HHS has since announced plans to appeal the ruling.
Adding further complexity, advisory committee member Dr. Robert Malone suggested via social media that the panel would be dissolved and reconstituted to sidestep a prolonged legal battle. However, an HHS spokesperson cautioned that any unofficial statements about next steps remain speculative until formally announced.
Legal pressure continues to mount. The American Academy of Pediatrics, which filed the original lawsuit challenging Kennedy's vaccine policies, made clear it will contest any committee restructuring that fails to meet proper legal and procedural standards.
As public health stakeholders await the appointment of a permanent CDC director, the agency's stability and its vaccine advisory framework remain central issues shaping the future of U.S. health policy.
